Do patients screened for hepatocellular carcinoma die significantly older? | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article Text

PostScript

Letter

Do patients screened for hepatocellular carcinoma die significantly older?

Alain Braillon

Correspondence to Alain Braillon, Gres 27 rue Voiture, Amiens 80000, France; braillon.alain{at}gmail.com

http://dx.doi.org/10.1136/gut.2011.241273

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

El-Serag et al showed that screening is a complex issue which necessitates a national programme to ensure participation, quality control and evaluation of the results, which is not yet the case in 2011. …

Footnotes

Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.

Read the full text or download the PDF: